Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase Beta Therapy in Patients With Fabry Disease
Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2006080816
Full Text
Open PDFAbstract
Available in full text
Date
April 4, 2007
Authors
Publisher
American Society of Nephrology (ASN)